Literature DB >> 8699215

Distribution of prescription drug exposures in the elderly: description and implications.

G Anderson1, K Kerluke.   

Abstract

Using data from a comprehensive prescription drug benefit program in British Columbia, we studied the distribution of prescription drug expenditures and exposures in the community-dwelling elderly over a 1-year period. Overall, 84% of the population was exposed to at least one prescription drug. The 11% of individuals with the highest level of use accounted for 50% of total drug expenditures. Individuals 65 to 74 years of age were exposed to a median of 2.2 different drugs during the year compared to a median of 3.8 for those 75 years of age and over. Twenty-four percent of the 65- to 74-year-old population were exposed to six or more different drugs during a 1-year period compared to 37% of the 75 years and over population. Central nervous system and cardiovascular drugs were most commonly responsible for multiple drug exposures. Forty-eight percent of the individuals exposed to six or more different drugs received prescriptions from three or more different physicians. In British Columbia, 98% of the elderly receiving six or more different drugs received at least one prescription from a general practitioner or a family practitioner.

Entities:  

Mesh:

Year:  1996        PMID: 8699215     DOI: 10.1016/0895-4356(96)00055-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  8 in total

Review 1.  Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients.

Authors:  D B Hogan
Journal:  CMAJ       Date:  1997-10-15       Impact factor: 8.262

2.  Polypharmacy among disabled Taiwanese elderly: a longitudinal observational study.

Authors:  Ding-Cheng Derrick Chan; Yi-Ting Hao; Shwu-Chong Wu
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 3.  Variability in the prescription of cardiovascular medications in older patients: correlates and potential explanations.

Authors:  Cinzia Maraldi; Fabrizia Lattanzio; Graziano Onder; Massimo Gallerani; Silvia Bustacchini; Giuseppe De Tommaso; Stefano Volpato
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

4.  Epidemiology of suboptimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy.

Authors:  Francesco Lapi; Claudia Pozzi; Giampiero Mazzaglia; Andrea Ungar; Stefano Fumagalli; Niccolò Marchionni; Pierangelo Geppetti; Alessandro Mugelli; Mauro Di Bari
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 5.  Medication withdrawal trials in people aged 65 years and older: a systematic review.

Authors:  Shoba Iyer; Vasi Naganathan; Andrew J McLachlan; David G Le Couteur
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  A population-based study on the association between acute renal failure (ARF) and the duration of polypharmacy.

Authors:  Yi-Ping Chang; San-Kuei Huang; Ping Tao; Ching-Wen Chien
Journal:  BMC Nephrol       Date:  2012-08-30       Impact factor: 2.388

7.  Clinical implications of changes in hepatic drug metabolism in older people.

Authors:  Sarah N Hilmer; Gillian M Shenfield; David G Le Couteur
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

8.  Factors Associated with Women's Medication Use.

Authors:  Jennifer Payne; Ineke Neutel; Robert Cho; Marie DesMeules
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.